This Article Full Text Full Text (PDF) Erratum (v17,p1330) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Slade, M. J. Articles by Coombes, R. C. Search for Related Content PubMed PubMed Citation Articles by Slade, M. J. Articles by Coombes, R. C. Social Bookmarking                            What's this?

Quantitative Polymerase Chain Reaction for the Detection of Micrometastases in Patients With Breast Cancer

From the Cancer Research Campaign Laboratories, Department of Cancer Medicine, Imperial College School of Medicine; Department of Surgery, Charing Cross Hospital; and Department of Haematology, Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom.

Address reprint requests to Martin J. Slade, MD, Cancer Research Campaign Laboratories, Department of Cancer Medicine, Imperial College School of Medicine, St. Dunstan's Rd, London W6 8RP, United Kingdom; email m.slade{at}cxwms.ac.uk

PURPOSE: Previous reports have indicated that reverse transcriptase polymerase chain reaction (RT-PCR) for cytokeratin 19 (CK-19) may be useful in the management of patients with breast cancer. However, the specificity of this technique is low, principally because of a high rate of false-positive results. To improve the specificity of this assay, we developed a quantitative RT-PCR methodology that enables an estimate to be made of the number of CK-19 transcripts in blood and bone marrow samples.

PATIENTS AND METHODS: We examined 45 peripheral-blood samples and 30 bone marrow samples from patients with a variety of nonneoplastic conditions using nested RT-PCR for CK-19. We also examined bone marrow and peripheral-blood samples from 23 patients with primary breast cancer and peripheral-blood samples from 37 patients with metastatic breast cancer. The number of CK-19 transcripts was estimated in positive specimens by competitive PCR and normalized to the number of ABL transcripts as an internal control for the quality and quantity of cDNA. RT-PCR results were compared with the numbers of CK-19–positive cells detected by immunocytochemistry.

RESULTS: Analysis of samples from patients without cancer enabled us to define an upper limit for the background ratio of CK-19 to ABL transcripts (1:1,000 for blood samples and 1:1,600 for bone marrow samples). Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer. Only three of 23 (13%) primary breast cancer peripheral-blood samples and none of the control samples were positive by these criteria. Only two of 23 patients (9%) with primary breast cancer showed immunocytochemically detectable cells in the blood; 10 of 23 (43%) showed immunocytochemically detectable cells in the bone marrow. Of 36 patients with metastatic breast cancer, eight (22%) showed positive events.

CONCLUSION: Quantitative RT-PCR for CK-19 detects a percentage of patients with breast cancer and may enable the progression or regression of the disease to be monitored.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. C. Hu, M. J. Booth, G. Tripuraneni, D. Davies, S. A.A. Zaidi, M. Tamburo de Bella, M. J. Slade, S. B. Marley, M. Y.A. Gordon, R. S. Coffin, et al. A Novel HSV-1 Virus, JS1/34.5-/47-, Purges Contaminating Breast Cancer Cells From Bone Marrow. Clin. Cancer Res., November 15, 2006; 12(22): 6853 - 6862. [Abstract] [Full Text] [PDF]

				J. Backus, T. Laughlin, Y. Wang, R. Belly, R. White, J. Baden, C. J. Min, A. Mannie, L. Tafra, D. Atkins, et al. Identification and Characterization of Optimal Gene Expression Markers for Detection of Breast Cancer Metastasis J. Mol. Diagn., August 1, 2005; 7(3): 327 - 336. [Abstract] [Full Text] [PDF]

				W. Janni, B. Rack, K. Lindemann, and N. Harbeck Detection of Micrometastatic Disease in Bone Marrow: Is It Ready for Prime Time? Oncologist, August 1, 2005; 10(7): 480 - 492. [Abstract] [Full Text] [PDF]

				V. Bozionellou, D. Mavroudis, M. Perraki, S. Papadopoulos, S. Apostolaki, E. Stathopoulos, A. Stathopoulou, E. Lianidou, and V. Georgoulias Trastuzumab Administration Can Effectively Target Chemotherapy-Resistant Cytokeratin-19 Messenger RNA-Positive Tumor Cells in the Peripheral Blood and Bone Marrow of Patients With Breast Cancer Clin. Cancer Res., December 15, 2004; 10(24): 8185 - 8194. [Abstract] [Full Text] [PDF]

				A M Gilbey, D Burnett, R E Coleman, and I Holen The detection of circulating breast cancer cells in blood J. Clin. Pathol., September 1, 2004; 57(9): 903 - 911. [Abstract] [Full Text] [PDF]

				J.-Y. Pierga, C. Bonneton, A. Vincent-Salomon, P. de Cremoux, C. Nos, N. Blin, P. Pouillart, J.-P. Thiery, and H. Magdelenat Clinical Significance of Immunocytochemical Detection of Tumor Cells Using Digital Microscopy in Peripheral Blood and Bone Marrow of Breast Cancer Patients Clin. Cancer Res., February 15, 2004; 10(4): 1392 - 1400. [Abstract] [Full Text] [PDF]

				K. Pantel, V. Muller, M. Auer, N. Nusser, N. Harbeck, and S. Braun Detection and Clinical Implications of Early Systemic Tumor Cell Dissemination in Breast Cancer Clin. Cancer Res., December 15, 2003; 9(17): 6326 - 6334. [Abstract] [Full Text] [PDF]

				M. Mitas, L. Hoover, G. Silvestri, C. Reed, M. Green, A. T. Turrisi, C. Sherman, K. Mikhitarian, D. J. Cole, M. I. Block, et al. Lunx Is a Superior Molecular Marker for Detection of Non-Small Lung Cell Cancer in Peripheral Blood J. Mol. Diagn., November 1, 2003; 5(4): 237 - 242. [Abstract] [Full Text] [PDF]

				A. Stathopoulou, A. Gizi, M. Perraki, S. Apostolaki, N. Malamos, D. Mavroudis, V. Georgoulias, and E. S. Lianidou Real-Time Quantification of CK-19 mRNA-Positive Cells in Peripheral Blood of Breast Cancer Patients Using the Lightcycler System Clin. Cancer Res., November 1, 2003; 9(14): 5145 - 5151. [Abstract] [Full Text] [PDF]

				M. S. Ismail, W. Wynendaele, J. L. E. Aerts, R. Paridaens, L. Van Mellaert, J. Anne, R. Gaafar, N. Shakankiry, H. M. Khaled, M. R. Christiaens, et al. Real-time quantitative RT-PCR and detection of tumour cell dissemination in breast cancer patients: plasmid versus cell line dilutions Ann. Onc., August 1, 2003; 14(8): 1241 - 1245. [Abstract] [Full Text] [PDF]

				N. Xenidis, I. Vlachonikolis, D. Mavroudis, M. Perraki, A. Stathopoulou, N. Malamos, C. Kouroussis, S. Kakolyris, S. Apostolaki, N. Vardakis, et al. Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer Ann. Onc., June 1, 2003; 14(6): 849 - 855. [Abstract] [Full Text] [PDF]

				R. A. Wascher, K. T. Huynh, A. E. Giuliano, N. M. Hansen, F. R. Singer, D. Elashoff, and D. S. B. Hoon Stanniocalcin-1: A Novel Molecular Blood and Bone Marrow Marker for Human Breast Cancer Clin. Cancer Res., April 1, 2003; 9(4): 1427 - 1435. [Abstract] [Full Text] [PDF]

				M. R. Weihrauch, E. Skibowski, T. C. Koslowsky, W. Voiss, D. Re, F. Kuhn-Regnier, C. Bannwarth, M. Siedek, V. Diehl, and H. Bohlen Immunomagnetic Enrichment and Detection of Micrometastases in Colorectal Cancer: Correlation With Established Clinical Parameters J. Clin. Oncol., November 1, 2002; 20(21): 4338 - 4343. [Abstract] [Full Text] [PDF]

				A. Stathopoulou, I. Vlachonikolis, D. Mavroudis, M. Perraki, Ch. Kouroussis, S. Apostolaki, N. Malamos, S. Kakolyris, A. Kotsakis, N. Xenidis, et al. Molecular Detection of Cytokeratin-19-Positive Cells in the Peripheral Blood of Patients With Operable Breast Cancer: Evaluation of Their Prognostic Significance J. Clin. Oncol., August 15, 2002; 20(16): 3404 - 3412. [Abstract] [Full Text] [PDF]

				B. Taback, A. D. Chan, C. T. Kuo, P. J. Bostick, H.-J. Wang, A. E. Giuliano, and D. S. B. Hoon Detection of Occult Metastatic Breast Cancer Cells in Blood by a Multimolecular Marker Assay: Correlation with Clinical Stage of Disease Cancer Res., December 1, 2001; 61(24): 8845 - 8850. [Abstract] [Full Text] [PDF]

				A. Ghadersohi and A. K. Sood Prostate Epithelium-derived Ets Transcription Factor mRNA Is Overexpressed in Human Breast Tumors and Is A Candidate Breast Tumor Marker and A Breast Tumor Antigen Clin. Cancer Res., September 1, 2001; 7(9): 2731 - 2738. [Abstract] [Full Text] [PDF]

				A. Wu, A. Mazumder, R. L. Martuza, X. Liu, M. Thein, K. R. Meehan, and S. D. Rabkin Biological Purging of Breast Cancer Cells Using an Attenuated Replication-competent Herpes Simplex Virus in Human Hematopoietic Stem Cell Transplantation Cancer Res., April 1, 2001; 61(7): 3009 - 3015. [Abstract] [Full Text]

				S. Braun and K. Pantel Clinical Significance of Occult Metastatic Cells in Bone Marrow of Breast Cancer Patients Oncologist, April 1, 2001; 6(2): 125 - 132. [Abstract] [Full Text]

				I. Miyashiro, C. Kuo, K. Huynh, A. Iida, D. Morton, A. Bilchik, A. Giuliano, and D. S.B. Hoon Molecular Strategy for Detecting Metastatic Cancers with Use of Multiple Tumor-specific MAGE-A Genes Clin. Chem., March 1, 2001; 47(3): 505 - 512. [Abstract] [Full Text] [PDF]

				B. Gerber, A. Krause, H. Muller, D. Richter, T. Reimer, J. Makovitzky, C. Herrnring, U. Jeschke, G. Kundt, and K. Friese Simultaneous Immunohistochemical Detection of Tumor Cells in Lymph Nodes and Bone Marrow Aspirates in Breast Cancer and Its Correlation With Other Prognostic Factors J. Clin. Oncol., February 15, 2001; 19(4): 960 - 971. [Abstract] [Full Text] [PDF]

				K. J. Martin, E. Graner, Y. Li, L. M. Price, B. M. Kritzman, M. V. Fournier, E. Rhei, and A. B. Pardee High-sensitivity array analysis of gene expression for the early detection of disseminated breast tumor cells in peripheral blood PNAS, February 15, 2001; (2001) 41622398. [Abstract] [Full Text]

				J.-C. Goeminne, T. Guillaume, M. Federico, R. Sabbatini, M. Morselli, R. Depenni, K. Cagossi, M. Luppi, G. Torelli, and V. Silingardi Detection of Circulating Tumor by Reverse Transcriptase Polymerase Chain Reaction J. Clin. Oncol., September 17, 2000; 18(17): 3196 - 3197. [Full Text] [PDF]

				M. J. Liptay, G. A. Masters, D. J. Winchester, B. L. Edelman, B. J. Garrido, T. R. Hirschtritt, R. M. Perlman, and W. A. Fry Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer Ann. Thorac. Surg., August 1, 2000; 70(2): 384 - 389. [Abstract] [Full Text] [PDF]

				J. W. Donovan, M. Ladetto, G. Zou, D. Neuberg, C. Poor, D. Bowers, and J. G. Gribben Immunoglobulin heavy-chain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia Blood, April 15, 2000; 95(8): 2651 - 2658. [Abstract] [Full Text] [PDF]

				B. M. Smith, M. J. Slade, J. English, H. Graham, M. Luchtenborg, H. D. Sinnett, N. C. P. Cross, and R. C. Coombes Response of Circulating Tumor Cells to Systemic Therapy in Patients With Metastatic Breast Cancer: Comparison of Quantitative Polymerase Chain Reaction and Immunocytochemical Techniques J. Clin. Oncol., April 7, 2000; 18(7): 1432 - 1439. [Abstract] [Full Text] [PDF]

				Antonella De Luca, S. Pignata, A. Casamassimi, A. D’Antonio, C. Gridelli, A. Rossi, F. Cremona, V. Parisi, Andrea De Matteis, and N. Normanno Detection of Circulating Tumor Cells in Carcinoma Patients by a Novel Epidermal Growth Factor Receptor Reverse Transcription-PCR Assay Clin. Cancer Res., April 1, 2000; 6(4): 1439 - 1444. [Abstract] [Full Text]

				J. A. Shaw, B. M. Smith, T. Walsh, S. Johnson, L. Primrose, M. J. Slade, R. A. Walker, and R. C. Coombes Microsatellite Alterations in Plasma DNA of Primary Breast Cancer Patients Clin. Cancer Res., March 1, 2000; 6(3): 1119 - 1124. [Abstract] [Full Text]

				K. J. Martin, E. Graner, Y. Li, L. M. Price, B. M. Kritzman, M. V. Fournier, E. Rhei, and A. B. Pardee High-sensitivity array analysis of gene expression for the early detection of disseminated breast tumor cells in peripheral blood PNAS, February 27, 2001; 98(5): 2646 - 2651. [Abstract] [Full Text] [PDF]